Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis
Chung, J.; Vallurupalli, M.; Noel, S.; Schor, G.; Liu, Y.; Nobrega, C.; Perera, J.; Wrona, E.; Hu, M.; Lin, Y.; Wu, D. w.; Saberi, M.; Scapozza, I.; Cruickshank, A.; Woods, E. C.; Chuong, C. L.; Birocchi, F.; Kammula, A.; Avila, O. I.; Kocak, M.; Doench, J. G.; Procter, D.; Thornton, L.; Brunner, A. M.; Winer, E.; DeAngelo, D. J.; Garcia, J. S.; Stone, R. M.; Jenkins, R. W.; Maus, M. V.; Graubert, T. A.; Yates, K. B.; Golub, T. R.; Manguso, R. T.
Show abstract
Macrophages in the tumor microenvironment exert potent anti-tumorigenic activity through phagocytosis. Yet therapeutics that enhance macrophage phagocytosis have not improved outcomes in clinical trials for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). To systematically identify regulators of phagocytosis, we performed genome-scale CRISPR knockout screens in human leukemia cells co-cultured with human monocyte-derived macrophages. Surprisingly, we found that whereas the classic "dont eat me" signal CD47 inhibited mouse macrophages, it did not inhibit phagocytosis by human macrophages. In contrast, the O-linked glycosylation and sialylation pathways were strong negative regulators of phagocytosis. In AML, the cell surface O-linked glycoprotein CD43 was the major effector of the O-linked glycosylation and sialylation pathways. Genetic deletion or antibody blockade of CD43 enhanced macrophage phagocytosis. This work highlights the importance of using human platforms to identify immune checkpoints, and nominates CD43 as a glyco-immune regulator of human macrophage phagocytosis.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia 96%
- Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia 96%
- An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML 95%
Similar papers in this journal
- When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer 95%
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers 95%
- TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function 95%
Similar papers in this journal
- Binary outcomes of enhancer activity underlie stable random monoallelic expression 95%
- Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation 94%
- Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia 94%
Similar papers in this journal
- Germline RUNX1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia 95%
- Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia 94%
- CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.